Xiaona Chang
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Jia Liu (17 shared papers)Xiu Nie (12 shared papers)Guang Wang (6 shared papers)Bo Huang (3 shared papers)Huaxiong Pan (4 shared papers)Lin Ma (1 shared paper)Hua Su (1 shared paper)Xia Xu (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Frontiers in Endocrinology (3 papers)European Journal of Preventive Cardiology (2 papers)Cancer Medicine (2 papers)BMC Cardiovascular Disorders (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Xiaona Chang
43 papers receiving 458 citations
Peers
Comparison fields: 5 of 64
- Nephrology 24
- Oncology 90
- Infectious Diseases 61
- Cancer Research 36
- Neurology 31
Countries citing papers authored by Xiaona Chang
This map shows the geographic impact of Xiaona Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaona Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaona Chang more than expected).
Fields of papers citing papers by Xiaona Chang
This network shows the impact of papers produced by Xiaona Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaona Chang. The network helps show where Xiaona Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaona Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2014 | 45 | |
| 3 | 2022 | 27 | |
| 4 | 2022 | 26 | |
| 5 | 2016 | 25 | |
| 6 | 2015 | 25 | |
| 7 | 2021 | 24 | |
| 8 | 2017 | 24 | |
| 9 | 2023 | 24 | |
| 10 | 2022 | 20 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2025 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2021 | 6 |
About Xiaona Chang
Xiaona Chang is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Physiology and Surgery, having authored 49 papers that have together received 463 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Thyroid Disorders and Treatments (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Nutrition and Health in Aging (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Nephrology (24 citations), Oncology (90 citations), Infectious Diseases (61 citations), Cancer Research (36 citations) and Neurology (31 citations). Xiaona Chang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Jia Liu, Xiu Nie, Guang Wang, Bo Huang, Huaxiong Pan, Lin Ma, Hua Su, Xia Xu, Ming Yang and Jiaxuan Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Endocrinology, European Journal of Preventive Cardiology, Cancer Medicine and BMC Cardiovascular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.